ABSTRACT Type 1 fimbriae of E. coli, a chaperon-usher bacterial adhesin, are synthesized by the majority of strains of the bacterium. Although frequently produced by commensal strains, the adhesin is nevertheless a virulence factor in Extraintestinal Pathogenic E. coli (ExPEC). The role of the adhesin in pathogenesis is best understood in Uropathogenic E. coli (UPEC). Host attachment and invasion by type 1 fimbriate bacteria activates inflammatory pathways, with TLR4 signaling playing a predominant role. In a mouse model of cystitis, type 1 fimbriation not only enhances UPEC adherence to the surface of superficial umbrella cells of the bladder urothelium, but is both necessary and sufficient for their invasion. Moreover the adhesin plays a role in the formation of transient intracellular bacterial communities (IBCs) within the cytoplasm of urothelial cells as part of UPEC cycles of invasion. The expression of type 1 fimbriation is controlled by phase variation at the transcriptional level, a mode of gene regulation in which bacteria switch reversibly between fimbriate and afimbriate phases. Phase variation has been widely considered to be a mechanism enabling immune evasion. Notwithstanding the apparently random nature of phase variation, switching of type 1 fimbrial expression is nevertheless controlled by a range of environmental signals that include the amino sugars sialic acid and N-acetylglucosamine (GlcNAc). Sialic acid plays a pivotal role in innate immunity, including signaling by the toll-like receptors. Here how sialic acid and GlcNAc control type 1 fimbriation is described and the potential significance of this regulatory response is discussed.
INTRODUCTION
Type 1 fimbriae of Escherichia coli, a member of the chaperon-usher family of bacterial adhesins, are synthesised by the majority of strains of the bacterium. Although frequently produced by commensal strains, the adhesin is nevertheless a virulence factor in extraintestinal pathogenic E. coli (ExPEC). The role of the adhesin in pathogenesis is best understood in uropathogenic E. coli (UPEC). Host attachment and particularly invasion by type 1 fimbriate bacteria activates inflammatory pathways, with TLR4 signalling playing a predominant role (1) . In a mouse model of cystitis, type 1 fimbriation not only enhances UPEC adherence to oligomannosides of uroplakin 1a on the surface of superficial umbrella cells of the bladder urothelium, but is both necessary and sufficient for their invasion (2, 3) . Moreover, more surprisingly, the adhesin plays a role in the formation of transient intracellular bacterial communities (IBCs) within the cytoplasm of urothelial cells as part of UPEC cycles of invasion (4) .
The expression of type 1 fimbriation is controlled by phase variation at the transcriptional level, a mode of gene regulation in which bacteria switch reversibly between fimbriate and afimbriate phases. Phase variation has been widely considered a mechanism enabling immune evasion, although alternative explanations for the phenomenon do exist (5) . Notwithstanding the apparently random nature of phase variation, switching of type 1 fimbrial expression is nevertheless controlled by a range of environmental signals that include the amino sugars sialic acid and N-acetylglucosamine (GlcNAc). Sialic acid plays a pivotal role in innate immunity, including signalling by the toll-like receptors. Here how sialic acid and GlcNAc control type 1 fimbriation is described and the potential significance of this regulatory response is discussed.
The Regulation of Type 1 Fimbriation
The genes required for the expression of type 1 fimbriation are situated at around 98 minutes on the genome of E. coli K-12. The adhesin's expression is controlled by the inversion of a short (314 bp) element of DNA (fimS) that contains the promoter required for the transcription of the operon that encodes the fimbrial structural genes (fimAICDFGH) (6) . An example of site-specific recombination, the inversion produces reversible switching (phase variation) in the adhesin's expression. Inversion of fimS is catalysed by the tyrosine recombinases FimB and FimE, which are encoded by genes fimB and fimE that lie upstream of fimS in the on or fimbriate orientation (7, 8) . While FimB catalyses inversion in either direction at a relatively low frequency (∼10 -3 per cell per generation), FimE is capable of promoting on-to-off inversion with both high frequency (up to 0.7 per cell per generation) and specificity (9) (10) (11) . Thus at equilibrium the relative activities of FimB and FimE favour the afimbriate phase, with FimB playing a key role in determining the proportion of fimbriate bacteria. Additional recombinases that can also catalyse the inversion of fimS, while not present in E. coli K-12, have been identified elsewhere on the genomes of some pathogenic strains of the bacterium (12, 13) .
In addition to the recombinases, integration host factor (IHF) and the leucine-responsive regulatory protein (Lrp) also play a direct role in fimS inversion (14, 15) . The invertible element is relatively short (∼314 bp) and the asymmetric binding of IHF and Lrp to sites within fimS presumably allows the DNA bending necessary to bring the two sites of recombination (IRL and IRR) into a juxtaposition for synapses and strand exchange (16) . Phase switching, while apparently random, is nevertheless controlled by a range of environmental signals that affect either recombinase gene expression or the inversion of fimS directly. For example, the branched-chain amino acids and alanine stimulate the fim inversion by promoting the formation of an Lrp nucleoprotein complex that enhances recombination over an alternative complex that does not (11, 17) . The inversion of fimS is also affected by temperature, pH, osmolarity and oxygen availability among other signals (11, (18) (19) (20) . fimB expression and hence type 1 fimbriation is inhibited selectively by the amino sugars N-acetylglucosamine (GlcNAc) and sialic acid (21, 22) .
Sialic Acids: Their Role in Host Immunity and E. coli Metabolism Sialic acids, a family of naturally-occurring nine-carbon keto amino sugars, are found almost exclusively in animals of the deuterostome lineage. When present in the glycan chains of glycoproteins and glycolipids they occupy the terminal position, providing cell-surface receptors for both host and microbial lectins alike. Sialic acids play a critical and complex role in the immune system, inhibiting the innate immune response by engaging Siglecs (Sialic acid-binding immunoglobulin-type lectins) on immune cells and by preventing the activation of complement by recruiting factor H (23). More rarely, sialic acids are present on bacterial and protozoan animal pathogen cell surfaces, where they enhance virulence by enabling the microorganisms to masquerade as self and hence suppress host defences.
While the ability of pathogens to decorate their surfaces with sialic acid is comparatively rare, many more bacteria that occupy an animal niche can utilise sialic acid as a carbon, nitrogen and energy source (24) . However, among this group only a subset of bacteria possess sialidases able to liberate free sialic acid from glycan chains. Those that are able to metabolise sialic acid, but which do not produce a sialidase, must rely upon other microorganisms, or the host itself, to release sialic acid from glycoconjugates before it can be used. Both E. coli and S. typhimurium, which fall into this latter category, appear to utilise sialic acid in the course of infection (25, 26) . For example, UPEC mutants unable to metabolise sialic acid are attenuated for growth in a murine model of bacteremia (25) . These results, while open to alternative interpretations as discussed below, nevertheless imply that sialic acid, presumably released by host sialidases, is available to E. coli in the bloodstream. While sialic acid metabolism does not appear to enhance UPEC virulence in the murine model of cystitis, the genes for its utilisation are induced in human urine (27) .Free sialic acid levels are among a small group of compounds that are increased in the urine of cystitis patients (28) . Sialic acid also appears to be available to E. coli in the urinary tract.
In E. coli, the metabolism of the most abundant form of sialic acid (N-acetylneuraminic acid or Neu5Ac) to N-acetylglucosamine-6-phosphate (GlcNAc-6-P) requires the nanATEK operon (29) . To enter glycolysis, GlcNAc-6-P is converted to fructose-6-phosphate by the sequential action of N-acetylglucosamine-6-phosphate deacetylase (NagA), generating GlcN-6-P, and glucosamine-6-phosphate deaminase (NagB) ( Fig. 1) (30) . However, GlcN-6-P can also be converted to GlcN-1-P, the precursor of UDP-GlcNAc required for both peptidoglycan and LPS biosynthesis, by phosphoglucosamine mutase (GlmM). Thus, sialic acid metabolism provides intermediates for both central metabolism and cell wall biosynthesis. The uptake of Neu5Ac across the cytoplasmic membrane, which occurs without modification, requires NanT, while its catabolism to GlcNAc-6-P requires N-acetylneuraminate aldolase (NanA), which generates N-acetylmannosamine and pyruvate, together with Nacetylmannosamine kinase (NanK) and N-acetylmannosamine-6-phosphate-2-epimerase (NanE) (24, 31) .
The expression of the nanATEK operon is repressed by the transcriptional regulator NanR, which is induced by sialic acid, and activated by CRP (cAMP receptor protein) (32, 33) . The nagAB operon is repressed by NagC and induced by GlcNAc-6-P (34, 35) . Accumulation of intracellular sialic acid in a nanA mutant is growth inhibitory, indicating that the interaction of sialic acid with one or more additional targets is detrimental to the cell (29) . On the other hand, sialic acid also inhibits the growth of a nanR mutant, but not a nanR nagC double mutant, suggesting that excess GlcNAc-6-P is also detrimental (36) . Thus, it seems that both the uptake of sialic acid, and the rate of its catabolism, require careful regulation to avoid growth inhibition. FIGURE 1 A model for the sialic acid Neu5Ac utilisation pathway of E. coli. Sialic acids, released from glycoconjugates in the α-anomer, cross the outer membrane by diffusion either through the sialic acid-selective channel NanC or the general porins OmpF and OmpC. The porins are presumably non-selective for the anomeric forms of Neu5Ac, so that any of the β-anomer formed spontaneously would also be taken up via this route (not shown). Periplasmic mutarotase NanM catalyses the rapid equilibrium of the α-anomer with the thermodynamically more stable β-anomer, before uptake by the inner membrane transporter NanT. Cytoplasmic Neu5Ac induces the nanATEK operon by converting NanR from the active transcriptional inhibitor (NanR A ) to the inactive form (NanR I ). Conversion of Neu5Ac to GlcNAc-6-P is catalysed by N-acetylneuraminate aldolase (NanA), which generates N-acetylmannosamine and pyruvate, together with N-acetylmannosamine kinase (NanK) and N-acetylmannosamine-6-phosphate-2-epimerase (NanE). To enter glycolysis, GlcNAc-6-P is converted to fructose-6-phosphate by N-acetylglucosamine-6-phosphate deacetylase (NagA), generating GlcN-6-P, followed by glucosamine-6-phosphate deaminase (NagB). The nagAB operon is induced by GlcNAc-6-P, which inactivates the transcriptional repressor NagC. GlcN-6-P can also be converted to UDPGlcNAc, required for both peptidoglycan and LPS biosynthesis, by the sequential action of phosphoglucosamine mutase (GlmM) and the bifunctional glucosamine-1-phosphate acetyltransferase and N-acetylglucosamine-1-phosphate uridyltransferase (GlmU). Proteins are shown in boxes (enzymes and porins in black-bordered boxes, while transcriptional regulators are bordered by red). The broken arrow linking GlcN-6-P to UDP-GlcNAc indicates that more than one step is involved. doi:10.1128/microbiolspec.MBP-0015-2014.f1
Given the toxicity of sialic acid in the absence of NanA, it is possible that this effect, rather than the loss of sialic acid as a nutrient, accounts for the attenuated growth of a nanA mutant of UPEC in the bloodstream (24, 25) .
The Regulation of fimB and the nanCMS Expression by Sialic Acid and GlcNAc fimB is separated from the divergently transcribed nanCMS operon (formally yjhATS respectively) by a large (>1.4-kbp) intergenic region (Fig. 2) . Both fimB and the nanCMS operon have long 5′ untranslated regions (5′-UTR) and share a set of cis-acting regulatory elements that are positioned close to the nan operon promoter (21, 22, 37) . Moreover, while fimA expression is suppressed by the small regulatory RNAs (sRNA) OmrA and OmrB, nanA expression is enhanced by these factors (38) . Thus, the expression of type 1 fimbriation and sialic acid metabolism are coordinated at a number of levels.
Initially it was determined that a 252 bp deletion (termed Δ2), more than 500 bp upstream of the fimB transcriptional start site, decreased fimB expression and FimB recombination five-and eighteen-fold respectively (21) . Substitution mutagenesis of the sequences within Δ2 localised two specific regions (termed region 1 and region 2 or NagC1 originally, but renamed O NR and O NC1 ) that stimulate fimB expression. Mutations in O NR have a lesser effect than those in O NC1 , while combination of both produced the greatest effect. O NR (underlined) falls within a 27 bp sequence (5′-ACCTTTATACCTGTTATACCAGATCAA) conserved upstream of both the nanATEK and yjhBC operons. This sequence, which includes the operator site for NanR, overlaps the known -10 region of both the nanATEK and nanCMS promoters (32, 37) .
O NR encompasses, and O NC1 lies immediately next to, Dam methylation sites (termed GATC
NanR and GATC NagC , respectively) that are unmodified in a subpopulation of cells (21, 22) . The pattern of protection and methylation indicates that the simultaneous protection of both sites occurs rarely, if at all. Whereas a mutation of nanR produces a loss of methylation protection at GATC NanR specifically, Neu 5 Ac inhibits protection at both GATC NanR and GATC NagC (22) . Further analysis shows that O NC1 binds NagC and that exogenous GlcNAc inhibits both fimB expression and FimB recombination. As expected, NagC is required for methylation protection at GATC NagC , and the addition of GlcNAc to growth medium, which generates GlcNAc-6-P on uptake, inhibits the methylation protection of GATC NagC selectively. Since, as noted above, Neu5Ac catabolism generates GlcNAc-6-P, the initially perplexing observation that Neu5Ac inhibits methylation protection at both sites is readily explained. Taken together, these observations support a model in which fimB expression is activated alternately by NanR and NagC, with GlcNAc inhibiting one, and Neu 5 Ac inhibiting both, of these pathways. In contrast, expression of the nanCMS operon is inhibited by these factors (37). As noted above, O NR overlaps the -10 region of the nanCMS operon promoter. NagC binding O NC1 prevents CRP binding to an overlapping operator site and hence inhibits activation of the nanCMS promoter.
NagC sites characteristically function in pairs, but although NagC binds to a second element (O NC2 ; originally termed NagC2) situated 212 bp closer to fimB than O NC1 , the cooperative binding of NagC to O NC1 and O NC2 was not apparent in early in vitro studies (32) . Furthermore a 304-bp deletion that included O NC2 (Δ3) did not diminish fimB expression. However, further work showed that a point mutation in O NC2 both diminishes fimB expression and results in a loss of the methylation protection of GATC NagC (39) . These apparent discrepancies were resolved by showing that NanR compensates for the loss of NagC activation of fimB in the Δ3 deletion mutant background. Furthermore, IHF was determined to bind to a site (ibs) midway between O NC1 and O NC2 to facilitate the cooperative binding of NagC to its two operator sites.
Further work demonstrates that fimB expression is also enhanced by SlyA, which binds to operator sites situated much closer to the fimB promoter than either NanR or NagC do (40) . Although the effects of NanR, NagC and SlyA on fimB expression are all diminished in the absence of the abundant nucleiod associated protein H-NS, neither NanR nor NagC require SlyA to activate fimB expression. How NagC-IHF and NanR are able to activate fimB expression from binding sites situated so far upstream of the fimB promoter remains unclear. What is clear, however, is that the dual control of fimB by NanR and NagC increases the effect of sialic acid on fimB expression, while enabling it to inhibition by GlcNAc too.
The Function of nanCMS Operon
Although Neu5Ac can cross the outer membrane by diffusion through the general porins OmpF and OmpC, NanC is a sialic acid specific channel (37, 41) . Growth on Neu5Ac is unaffected in a nanC mutant, but the activity of NanC suggests that the uptake of sialic acid through OmpF and OmpC is suboptimal in some circumstances. The pyranose ring of free sialic acid spontaneously alternates between alpha and beta anomers, with >90% of molecules existing in the thermodynamically more stable beta-anomeric form in solution. In contrast, sialic acid is trapped in the alpha-anomeric form in sialoconjugates and it is in this configuration that it is released by sialidases (24) . The second member of the nanC operon, nanM, encodes a periplasmic sialic acid mutarotase that accelerates the normally slow equilibrium between the anomeric forms of Neu5Ac (42) . This activity presumably allows E. coli to exploit sialic acid released from glycoconjugates more rapidly than would otherwise be possible. The final member of the nanC operon, nanS, encodes a sialyl esterase needed to convert Neu5,9Ac 2 to Neu5Ac to permit E. coli to use the 9-O acetylated sialic acid for growth (43, 44) . NanS is necessary for Neu5,9Ac 2 to induce expression of the NanR-regulated operons, suggesting that either NanT is unable to transport Neu5,9Ac 2 into the cytoplasm, or that Neu5,9Ac 2 is unable to induce NanR following its uptake (33) . Given that NanS seems to lack a signal sequence the later possibility appears to be more likely. While mutation of nanS abolishes growth on Neu5,9Ac 2 as the sole carbon source, mutations in nanC and nanM diminish it too (our unpublished data). This raises the possibility that NanC and NanM also play a role in Neu5,9Ac 2 metabolism, although further work is required to rule out polarity as an explanation for the effects of the nanC and nanM mutations.
The Regulation of Type 1 Fimbriation by Sialic Acid and its Potential Implications for the Host-parasite Relationship
It is well documented that the interaction of type 1 fimbriate bacteria with host cells is pro-inflammatory, with activation of TLR4 signalling being key in UPEC pathogenesis (1) . The release of sialic acid from the host surface is a pivotal step in the activation of inflammatory pathways by freeing Siglecs from cis inhibition by adjacent glycoconjugates (23) . We have proposed that E. coli recognises free sialic acid as an indicator of increased inflammation, providing the raison d'être for its effect on fimB expression (21) . As the release of sialic acid from host cell surfaces can enhance the binding of type 1 fimbriate E. coli (45) , this could be particularly important to prevent an escalating level of bacterial-host attachment and invasion leading to excessive inflammation and bacterial elimination. Moreover, while it has been known for some time that TLR4 signalling enables host sialidase Neu1 up-regulation (46) , it has only more recently been demonstrated that this overcomes an inhibitory TLR-Siglec interaction that acts as a break on the inflammatory response (47) . Thus, a direct link has now been established between the innate immune signalling pathway that type 1 fimbriate bacteria activate and the release of sialic acid from the host cell surface.
Notwithstanding the comments above, it is also apparent that the ability of some UPEC strains to respond adaptively to sialic acid in the course of infection in the mouse model of cystitis is limited (48) . UPEC infection of the mouse bladder is enhanced when the host is coinfected with Group B Streptococcus, even though the latter is eliminated rapidly from the urinary tract. This effect requires Siglec-E (the murine equivalent of Siglec-9) trans engagement with the Streptococcal sialic acid capsule (49) . The effect is attenuated in mice lacking an intact TLR4 signalling pathway. These observations demonstrate that the release of Siglec-sialic acid binding does have a detrimental effect on UPEC in this model system. The observations also imply that UPEC's ability to detect and respond appropriately to sialic acid was at best suboptimal in these experiments. One potential ASMscience.org/MicrobiolSpectrumcaveat in this work is that the UPEC strain used, UT189, does itself produce a sialic acid capsule (50) . Both the effect of the K1 capsule produced by this strain on Siglec signalling, and the bacterium's ability to recognise exogenous sialic acid, may differ from other UPEC isolates and it would be interesting to know if other, nonsialylated UPEC strains behave differently to UT189.
CONCLUDING REMARKS
As a signal of host immune function, free sialic acid is a potentially attractive candidate for bacteria, including E. coli. Sialic acid is restricted to animals and their pathogens in which it plays a crucial role in controlling innate immunity. Furthermore, while E. coli lacks a sialidase, and so is unable to release the amino sugar from host glycoconjugates, host sialidases liberate free monomers upon immune activation. The demonstration that type 1 fimbriation, which allows both host attachment and invasion, is inhibited by sialic acid is therefore intriguing. It seems possible that other virulence factors are also controlled by sialic acid. Following this line of reasoning, it would also be interesting to know if sialic acid induces the expression of antiinflammatory factors produced by UPEC, but absent from E. coli K-12 (51, 52) .
For E. coli to be able to recognise free sialic acid as a reliable indicator of host immune activation it would seem important for the bacterium to be able to distinguish somehow sialic acid released by the host from that liberated by microbial sialidases. In this respect, host sialidases are generally better able to catalyse the release of O-acetylation sialic acid than their microbial counterparts (24) . The presence of sialyl esterase (NanS) in E. coli and the close association between fimB and the nanCMS operon that encodes it may enhance the bacterium's ability to achieve this. Further work is also required to determine the functions of both NanC and NanM and the effect that the loss of both these proteins and NanS have on the interaction of E. coli with its animal hosts.
